Drug-associated blood dyscrasias

5Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Drugs have been associated with the development of thrombocytopenia, thrombotic thrombocytopenia purpura-haemolytic-uraemic syndrome, haemolytic anaemia, and agranulocytosis caused by direct dose-related toxicity and by immune-mediated mechanisms. This article will review the drugs associated with these blood dyscrasias, describe the presumptive mechanisms, and discuss treatment options. © 2001 Lippincott Williams & Wilkins.

References Powered by Scopus

Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature

818Citations
N/AReaders
Get full text

Heparin-induced thrombocytopenia: Towards consensus

572Citations
N/AReaders
Get full text

Enzymatic deficiency in primaquine-sensitive erythrocytes

472Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Idiosyncratic adverse reactions to antiepileptic drugs

306Citations
N/AReaders
Get full text

Population-based drug-induced agranulocytosis

174Citations
N/AReaders
Get full text

Detection and incidence of drug-induced agranulocytosis in hospital: A prospective analysis from laboratory signals

19Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Medina, P. J., & George, J. N. (2001). Drug-associated blood dyscrasias. Adverse Drug Reaction Bulletin. Lippincott Williams and Wilkins. https://doi.org/10.1097/00012995-200110000-00001

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

50%

Chemistry 1

50%

Save time finding and organizing research with Mendeley

Sign up for free